how long have glp 1 meds been around Research shows GLP-1 drugs are effective but complex The Multi-Sector Impacts of GLP-1RA

Short answer: Nonot without talking to your doctor

It functions better as a complement than a replacement

By improving glucose removal in white adipose tissue, tirzepatide restored insulin sensitivity even when there was no GLP- 1 receptor -induced weight loss

Clinical Trial Data for Weight Loss For semaglutide (Wegovy/Ozempic): According to the STEP clinical trial program published in major medical journals, adults using semaglutide 2.4 mg weekly (the Wegovy dose) in combination with lifestyle interventions experienced an average weight loss of approximately 15-20% of body weight over 68 weeks in controlled research settings , compared to approximately 2-3% in placebo groups

It is being studied in clinical trials, and Lilly has reported positive Phase 3 topline results, but investigational results are not the same as FDA approval

The critical next question is whether these interactions translate into measurable clinical benefit in real-world populations, and what the emerging evidence has to say about that